
UnitedHealth: Buy Or Sell UNH Stock At $325?
UnitedHealth's stock (NYSE:UNH) has undergone a noticeable decline, decreasing from a peak of around $600 in April to about $275 in May, and then making a slight recovery to $325. This drop followed the company's announcement of disappointing Q1 results, the later retraction of its earnings forecast, and sudden shifts in top management. While these occurrences have naturally raised concerns regarding UNH stock, it is also trading at very appealing valuations. Additionally, as outlined below, the company exhibits robust operating performance and financial health across key metrics such as Growth, Profitability, Financial Stability, and Downturn Resilience. Nevertheless, for those investors who prefer less volatility than individual stocks, the Trefis High Quality portfolio offers an alternative — having surpassed the S&P 500 and delivered returns greater than 91% since its inception. Separately, see – SOFI Stock To $30?
How Does UnitedHealth's Valuation Look vs. The S&P 500?
When considering what you pay per dollar of sales or profit, UNH stock appears inexpensive in relation to the broader market.
How Have UnitedHealth's Revenues Grown Over Recent Years?
UnitedHealth's Revenues have exhibited significant growth in recent years.
How Profitable Is UnitedHealth?
UnitedHealth's profit margins are significantly lower than those of most companies covered by Trefis.
Does UnitedHealth Look Financially Stable?
UnitedHealth's balance sheet appears robust.
How Resilient Is UNH Stock During A Downturn?
UNH stock has proven to be more resilient than the benchmark S&P 500 index during some recent downturns. As investors speculate on the possibility of a soft landing in the U.S. economy, how serious could it get if another recession strikes? Our dashboard How Low Can Stocks Go During A Market Crash shows how significant stocks fared during and after previous market crashes.
Putting All The Pieces Together: What It Means For UNH Stock
In conclusion, UnitedHealth's performance regarding the outlined metrics is as follows:
UnitedHealth has shown strong performance across the previously mentioned parameters. This, in conjunction with its current low valuation, renders the stock appealing and reinforces our finding that UNH represents a worthwhile buying opportunity.
Of course, there's always a level of uncertainty. In light of the recent challenges, including Centene's latest withdrawal of guidance, investors may be cautious about selecting UNH. However, for long-term investors, the presently discounted valuation is likely advantageous, especially given the company's consistent history of strong performance.
While UNH stock appears promising, investing in a single stock can carry risks. Conversely, the Trefis High Quality (HQ) Portfolio, comprising 30 stocks, has a history of comfortably outperforming the S&P 500 over the last 4-year period. What accounts for this? Collectively, HQ Portfolio stocks produced superior returns with lower risk compared to the benchmark index; providing a less turbulent experience, as demonstrated by HQ Portfolio performance metrics.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
29 minutes ago
- Yahoo
Nvidia Nears $4T Valuation, Overtakes Apple in Historic Market Cap Surge
July 4 - Shares of Nvidia (NASDAQ:NVDA) climbed about 2.4% Thursday to $160.98, lifting its market capitalization to roughly $3.92 trillion. That move briefly put Nvidia on track to surpass Apple (NASDAQ:AAPL), which closed at a record $3.915 trillion on Dec. 26, 2024. Microsoft (NASDAQ:MSFT) sits in second place with a market value near $3.65 trillion, while Apple holds about $3.17 trillion. Warning! GuruFocus has detected 4 Warning Signs with NVDA. Nvidia's jump reflects robust demand for its AI?focused chips, which power large language models and other compute?heavy applications. Remarkably, Nvidia now tops the combined value of all publicly listed companies in Canada and Mexico, as well as the total market cap of UK?traded firms, Reuters reported. Analysts warn that Nvidia's rally could face challenges if chip production scales up or geopolitical issues disrupt supply chains. Still, its pricing power and strong order backlog may help sustain investor interest. As Nvidia vies to become the most valuable company ever, market watchers will monitor whether it can maintain this momentum into the second half of 2025. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
29 minutes ago
- Yahoo
Mizuho's Top Analyst Sees Strong AI Upside in AMD Through 2025
July 3 - Mizuho Securities' top analyst Vijay Rakesh raised his price target on Advanced Micro Devices (NASDAQ:AMD) to $152 from $135, while maintaining a "Buy" rating. Rakesh pointed to robust AI traction and strong GPU demand as key drivers. He noted that AMD shares have climbed about 14% this year, including a roughly 60% surge over the past three months. Warning! GuruFocus has detected 3 Warning Signs with AMD. For the June quarter, Rakesh forecasts revenue of $7.40 billion but trimmed his EPS estimate to $0.47 from $0.68, slightly below the Street's $0.49. He left his full?year 2025 revenue outlook at $32 billion but cut EPS to $3.90 from $4.02. Looking further ahead, Rakesh lowered his 2026 EPS projection to $5.86 from $6.28, though this remains just above consensus of $5.81. He expects 2027 revenue to tick up modestly and kept EPS at $7.19. Rakesh highlighted the upcoming MI355X AI accelerator ramp in late 2025 as a potential catalyst. He also flagged ongoing software gaps that could limit AMD's ability to rival Nvidia (NVDA). Investors will watch whether AMD can translate AI momentum into sustained earnings growth. Based on the one year price targets offered by 40 analysts, the average target price for Advanced Micro Devices Inc is $132.14 with a high estimate of $200.00 and a low estimate of $95.00. The average target implies a downside of -4.19% from the current price of $137.91. Based on GuruFocus estimates, the estimated GF Value for Advanced Micro Devices Inc in one year is $167.94, suggesting a upside of +21.78% from the current price of $137.91. Gf value is Gurufocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. For deeper insights, visit the forecast page. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
31 minutes ago
- Yahoo
Here's Why Night Watch Investment Management Sold Its Stake in Remitly (RELY) in Q2
Night Watch Investment Management, an investment management firm, released its second-quarter 2025 investor letter. A copy of the letter can be downloaded here. In the second quarter, the fund LP appreciated by 23.31% net of fees, and YTD, its performance stood at 20.71%. The portfolio demonstrated resilience in the quarter, despite volatility in March and April. In addition, please check the fund's top five holdings to know its best picks in 2025. In its second-quarter 2025 investor letter, Night Watch Investment Management highlighted stocks such as Remitly Global, Inc. (NASDAQ:RELY). Remitly Global, Inc. (NASDAQ:RELY) offers digital financial services for immigrants, their families, and other citizens. The one-month return of Remitly Global, Inc. (NASDAQ:RELY) was -11.40%, and its shares gained 48.59% of their value over the last 52 weeks. On July 3, 2025, Remitly Global, Inc. (NASDAQ:RELY) stock closed at $18.50 per share, with a market capitalization of $3.771 billion. Night Watch Investment Management stated the following regarding Remitly Global, Inc. (NASDAQ:RELY) in its Q2 2025 investor letter: "We follow a diverse set of industries and are able to rapidly reposition in case an external factor such as politics changes the winners and the losers. The proposed tariffs, as well as the tax legislation that is currently being negotiated by the US Senate, will impact some industries and we have repositioned accordingly. A senior banker shaking hands with migrant customers in a corporate boardroom. Remitly Global, Inc. (NASDAQ:RELY) is not on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 46 hedge fund portfolios held Remitly Global, Inc. (NASDAQ:RELY) at the end of the first quarter, which was 35 in the previous quarter. The first quarter revenue of Remitly Global, Inc. (NASDAQ:RELY) increased 34% year-over-year to $361.6 million. While we acknowledge the potential of Remitly Global, Inc. (NASDAQ:RELY) as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. If you are looking for an AI stock that is as promising as NVIDIA but that trades at less than 5 times its earnings, check out our report about the undervalued AI stock set for massive gains. In another article, we covered Remitly Global, Inc. (NASDAQ:RELY) and shared the list of stocks expected to beat the market by 20 Percentage points this year. In addition, please check out our hedge fund investor letters Q1 2025 page for more investor letters from hedge funds and other leading investors. While we acknowledge the potential of RELY as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data